289 related articles for article (PubMed ID: 10674133)
1. Primary neuroendocrine carcinoma of the liver: difficult diagnosis of a rare neoplasm.
Ferrero A; Gallino C; D'Aloisio G; Gandini G; Garavoglia M
Acta Chir Belg; 1999 Dec; 99(6):299-302. PubMed ID: 10674133
[TBL] [Abstract][Full Text] [Related]
2. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature.
Donadon M; Torzilli G; Palmisano A; Del Fabbro D; Panizzo V; Maggioni M; Santambrogio R; Montorsi M
Eur J Surg Oncol; 2006 Apr; 32(3):325-8. PubMed ID: 16426802
[TBL] [Abstract][Full Text] [Related]
3. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
Huang YQ; Xu F; Yang JM; Huang B
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatic neuroendocrine tumor: an unusual cystic presentation.
Shetty PK; Baliga SV; Balaiah K; Gnana PS
Indian J Pathol Microbiol; 2010; 53(4):760-2. PubMed ID: 21045409
[TBL] [Abstract][Full Text] [Related]
5. Liver-directed therapies for metastatic neuroendocrine tumors.
Garrot C; Stuart K
Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease.
Liu DM; Kennedy A; Turner D; Rose SC; Kee ST; Whiting S; Murthy R; Nutting C; Heran M; Lewandowski R; Knight J; Gulec S; Salem R
Am J Clin Oncol; 2009 Apr; 32(2):200-15. PubMed ID: 19346815
[No Abstract] [Full Text] [Related]
7. Chemoembolization of hepatic malignancies.
Soulen MC
Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine liver metastases.
Reddy SK; Clary BM
Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
[TBL] [Abstract][Full Text] [Related]
11. Transhepatic artery chemoembolization for liver metastases of primary retroperitoneal endodermal sinus tumor. A case report.
Chen CL; Wang PH; Ng HT; Yuan CC
J Reprod Med; 1999 Jun; 44(6):559-62. PubMed ID: 10394553
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case.
Ishida M; Seki K; Tatsuzawa A; Katayama K; Hirose K; Azuma T; Imamura Y; Abraham A; Yamaguchi A
Surg Today; 2003; 33(3):214-8. PubMed ID: 12658390
[TBL] [Abstract][Full Text] [Related]
13. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
14. [Locoregional therapy of neuroendocrine tumors].
Roche A; Lasser P
Rev Prat; 2002 Feb; 52(3):274-8. PubMed ID: 11925717
[TBL] [Abstract][Full Text] [Related]
15. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
17. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
Nakakura EK; Venook AP; Bergsland EK
Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
[TBL] [Abstract][Full Text] [Related]
18. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
Christante D; Pommier S; Givi B; Pommier R
Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
[TBL] [Abstract][Full Text] [Related]
19. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
